Dan Liu
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Respiratory Support and Mechanisms
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Treatments and Mutations 27
- Lung Cancer Diagnosis and Treatment 21
- Oncology 51
- Lung Cancer Research Studies 12
- Inflammatory Biomarkers in Disease Prognosis 12
- Cancer Immunotherapy and Biomarkers 9
- Journals
- PLoS ONE (11 papers)BMC Cancer (5 papers)Medicine (5 papers)Frontiers in Oncology (5 papers)Scientific Reports (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dan Liu
232 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 155
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 475
- Oncology 845
- Critical Care and Intensive Care Medicine 153
- Infectious Diseases 467
Countries citing papers authored by Dan Liu
This map shows the geographic impact of Dan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Liu more than expected).
Fields of papers citing papers by Dan Liu
This network shows the impact of papers produced by Dan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Liu. The network helps show where Dan Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 22 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 1 | |
| 17 | 2018 | 44 | |
| 18 | 2018 | 79 | |
| 19 | 2015 | 4 | |
| 20 | 2013 | 1 |
About Dan Liu
Dan Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Nephrology and Critical Care and Intensive Care Medicine, having authored 253 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Research Studies (12 papers), Inflammatory Biomarkers in Disease Prognosis (12 papers), Radiomics and Machine Learning in Medical Imaging (10 papers), COVID-19 Clinical Research Studies (10 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (475 citations), Oncology (845 citations), Critical Care and Intensive Care Medicine (153 citations) and Infectious Diseases (467 citations). Dan Liu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weimin Li, Frank Weidemann, Georg Ertl, Binmiao Liang, Jian Luo, Kai Hu, Yu He, Jing Jin, Zongan Liang and Chengdi Wang. Their work appears in journals such as PLoS ONE, BMC Cancer, Medicine, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.